DEVELOPMENT OF A DISCRIMINATORY METHOD FOR DETERMINATION OF IN VITRO DISSOLUTION OF CILNIDIPINE
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i2.49160Keywords:
Cilnidipine, In-vitro dissolution method, Fast-dissolving filmAbstract
Objectives: This study involves the development of a discriminatory method to differentiate the in vitro dissolution of cilnidipine’s mouth-dispersing film from that of a commercial tablet.
Methods: The mouth-dispersing film was initially developed using a reported established method. A discriminatory dissolution method was developed to assess the in vitro dissolution of the mouth-dispersing film and compare the same with that of the commercial tablet.
Results: The study findings indicated the method employed was able to differentiate the dissolution of the fast-dissolving film from the commercial tablet. About 98.52±0.60% of the drug was found to be released from the oral film in 40 min whereas the tablet took nearly 5 h for 92.06±0.49% of the drug to get released.
Conclusion: These results demonstrate that the dissolution media identified was able to create the necessary sink condition that would be able to differentiate the dissolution profile of the mouth-dispersing film from the conventional tablet. The ultrasound spectrophotometric method employed was found to be simple rapid and sensitive enough to estimate the drug release from diverse pharmaceutical dosage forms.
Downloads
References
Yoshimoto R, Dohmoto H, Yamada K, Goto A. Prolonged inhibition of vascular contraction and calcium influx by the novel 1, 4-dihydropyridine calcium antagonist cilnidipine (FRC-8653). Jpn J Pharmacol 1991;56:225-9. doi: 10.1254/jjp.56.225, PMID 1881002
Proudfoot JR. Drug likeness and analogue‐based drug discovery. In: Analogue‐based Drug Discovery. New Jersey: John Wiley and Sons; 2006. p. 25-52.
Ando K. L-/N-type calcium channel blockers and proteinuria. Curr Hypertens Rev 2013;9:210-8. doi: 10.2174/157340211066614013115 5331, PMID 24479751
Harshitha KN, Shruthi BN, Bhagawati S. Design and characterization of fast dissolving films of cilnidipine solid dispersions. Am J Pharm Tech Res 2018;8:2249-3387. doi: 10.46624/ajptr.2018.v8.i4.017
Rekha MS, Sultana SK, Mahathi K, Parveen P, Prathima B, Devi AS. Formulation and evaluation of fast dissolving buccal film containing isradipine solid dispersion. Am J Pharmtech Res 2015;5:221-47.
Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: Innovations in formulation and technology. Int J Pharm Sci Rev Res 2011;9:50-7.
Hanif M, Zaman M, Chaurasiya V. Polymers used in buccal film: A review. Des Monomers Polym 2015;18:105-11. doi: 10.1080/ 15685551.2014.971389
Jyoti VJ, Rathore RP, Kapse SN. A comparative in-vitro dissolution and in-vivo bioavailability study of mouth dissolving film of promethazine hydrochloride against the marketed tablet formulation. Eur J Mol Clin Med 2021;8:2515-8260.
Haju SS, Yadav S. Formulation and evaluation of cilnidipine mucoadhesive buccal film by solvent casting technique for the treatment of hypertension. Int J Pharm Pharm Sci 2021;13:34-43.
Sheoran R. Fast dissolving oral films: A review with future prospects. Int J Pharm Pharm Res 2018;12:15-32.
Garsuch V, Breitkreutz J. Comparative investigations on different polymers for the preparation of fast-dissolving oral films. J Pharm Pharmacol 2010;62:539-45. doi: 10.1211/jpp.62.04.0018, PMID 20604845
Saini P, Kumar A, Sharma P, Visht S. Fast disintegrating oral films: A recent trend of drug delivery. Int J Drug Dev Res 2014;4:80-94.
Kaur P, Garg R. Oral dissolving film: Present and future aspects. J Drug Deliv Ther 2018;8:373-7. doi: 10.22270/jdt.v8i6.2050
Sharma D, Kaur D, Verma S, Singh D. Fast dissolving oral films technology: A recent trend for an innovative oral drug delivery system. Int J Drug Deliv 2015;7:60-75.
Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: An innovative drug delivery system and dosage form. Int J Chem Tech Res 2010;2:576-83.
Rao SV, Bhavya G, Padmalatha K. Mouth dissolving films: An effective oral disintegrating drug delivery system. Eur J Biomed Pharm Sci 2019;6:158-63.
Liu Q, Mai Y, Gu X, Zhao Y, Di X, Ma X, et al. A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability. J Drug Deliv Sci Technol 2020;55:101371. doi: 10.1016/j.jddst.2019.101371
Published
How to Cite
Issue
Section
Copyright (c) 2023 Vanita Somasekhar, Tejashwini H, Muralikrishna P V
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
